Episode Details
Back to Episodes
Pharmaceutical Executive Daily: New Study Finds No Evidence Linking Tylenol Use to Autism Risk
Published 3 months, 4 weeks ago
Description
In today’s Pharmaceutical Executive Daily, a new study reignites debate over a potential link between Tylenol use and autism risk, TopGum signs a $12 million letter of intent to acquire US manufacturing operations, and industry leaders weigh whether to build or buy AI capabilities amid accelerating digital transformation.